Regulation of mesangial cell proliferation by the mevalonate pathway

Contributions to Nephrology

Volumn 120, Issue , 1997, Pages 191-196

  Massy, Ziad A ^a,b   Guijarro, Carlos ^a   O'Donnell, Michael P ^a   Kasiske, Bertram L ^a   Keane, William F ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FARNESYL DIPHOSPHATE; GERANYLGERANYL PYROPHOSPHATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOPRENOID PHOSPHATE; MEVALONIC ACID; MEVINOLIN;

ANIMAL; CELL CULTURE; CELL DIVISION; CYTOLOGY; MESANGIUM; METABOLISM; REVIEW;

ANIMALS; CELL DIVISION; CELLS, CULTURED; CHOLESTEROL; GLOMERULAR MESANGIUM; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOVASTATIN; MEVALONIC ACID; POLYISOPRENYL PHOSPHATES;

EID: 0030625556     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000059837     Document Type: Article

References (21)

1. Floege J, Gröne HJ. Progression of renal failure: What is the role of cytokines? Nephrol Dial Transplant 1995;10:1575-1586.
2. Abboud HE: Growth factors and the mesangium. J Am Soc Nephrol 1992;2:S185-S189.
3. Johnson RJ: The glomerular response to injury: Progression or resolution? Kidney Int 1994;45:1796-1782.
4. Johnson RJ, Raines EW, Floege J, Yoshimura A, Pritzl P, Alpers C, Ross R: Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 1992;175:1413-1416.
5. Sinensky M, Lutz RJ: The prenylation of proteins. Bioessays 1992;14:25-31.
6. Carlberg M, Hjertman M, Wejde J, Larsson O: Mevalonate is essential for growth activation of human fibroblasts: Evidence for a critical role of protein glycosylation in the prereplicative period. Exp Cell Res 1994;212:359-366.
7. + antiporter in rat renal brush-border membrane. J Biol Chem 1988;263:13683-13691.
8. Chojnacki T, Dallner G: The biological role of dolichol. Biochem J 1988;251:1-9.
9. Goldstein JL, Brown MS: Regulation of the mevalonate pathway. Nature 1990;343:425-430.
10. Fogelman AM, Edmond J, Popják G: Metabolism of mevalonate in rats and man not leading to sterols. J Biol Chem 1975;250:1771-1775.
11. James GL, Goldstein JL, Brown MS: Polylysine and CVIM sequences of K-RasB dictate specificity of prenylation and confer resistance to benzodiazepine peptidomimetic in vitro. J Biol Chem 1995;270:6221-6226.
12. Ernster L, Dallner G: Biochemical, physiological and medical aspects of ubiquinone function. Biochim Biophys Acta 1995;1271:195-204.
13. O'Donnell MP, Kasiske BL, Kim Y, Atluru D, Keane WF: Lovastatin inhibits proliferation of rat mesangial cells. J Clin Invest 1993;91:83-87.
14. Massy ZA, Kasiske BL, Guijarro C, Kim Y, Keane WF, O'Donnell MP: Beyond farnesyl: Role of geranylgeranyl (GG) in human mesangial cell (HMC) DNA synthesis stimulated by PDGF(abstract). J Am Soc Nephrol 1995;6:800.
15. Grandaliano G, Biswas P, Choudhury GG, Abboud HE: Simvastatin inhibits PDGF-induccd DNA synthesis in human glomerular mesangial cells. Kidney Int 1993;44:503-508.
16. Harris KPG, Purkerson ML, Yates J, Klahr S: Lovastatin ameliorates the development of glomerulosclerosis and uremia in experimental nephrotic syndrome. Am J Kidney Dis 1990;15:16-23.
17. O'Donnell MP, Kasiske BL, Katz SA, Schmitz PG, Keane WF: Lovastatin but not enalapril reduces glomerular injury in Dahl salt-sensitive rats. Hypertension 1992;20:651-658.
18. Kasiske BL, O'Donnell MP, Garvis WJ, Keane WF: Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure. Circ Res 1988;62:367-374.
19. Kasiske BL, O'Donnell MP, Cleary MP, Keane WF: Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 1988;33:667-672.
20. Walli AK, Gröne E, Gröne HJ, Seidel D: Reduction of lipid induced glomerulopathy by lovastatin without significant decrease of plasma cholesterol levels in guinea pigs (abstract). Circulation 1994;90:1-233.
21. Nabeshima K, Yoshimura A, Inui K, Uda S, Sugenoya Y, Ideura T: HMG CoA reductase inhibitor suppresses initial macrophage infiltration and PDGF-induced mesangial cell proliferation in rats with mesangial proliferative nephritis in vivo (abstract). J Am Soc Nephrol 1994;5:789.